Global Topical Drug Delivery Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Topical Drug is one that is administered to the skin (or another external body surface such as a mucous membrane) to treat a condition of the skin (or other tissue to which the drug product is applied). The high prevalence of skin diseases and rising prevalence of eye diseases has led to the adoption of Topical Drug Delivery across the forecast period. For Instance: According to the WHO, between 2 and 3 million cases of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer are diagnosed annually across the globe. Also, with the delivery of biologics through the transdermal route, the adoption & demand for Topical Drug Delivery is likely to increase the market growth during the forecast period. However, preference for alternative modes of drug delivery impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Topical Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as high incidence of skin diseases (such as skin cancer), increasing use of contraceptives would create lucrative growth prospects for the Topical Drug Delivery Market across Asia-Pacific region.
Major market players included in this report are:
Cipla Ltd (India)
Johnson & Johnson (US)
Nestle SA (Switzerland)
Novartis AG (Switzerland)
GlaxoSmithKline (UK)
Bausch Health Companies (Canada)
Merck & Co (US)
Bayer AG (Germany)
Hisamitsu Pharmaceutical (Japan)
Glenmark Pharmaceuticals
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Semi-Solid Formulations
Liquid Formulations
Solid Formulations
Transdermal Products
By Use:
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019,2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Topical Drug Delivery Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Topical Drug Delivery Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Topical Drug Delivery Market, by Product, 2020-2028 (USD Billion)
- 1.2.3. Topical Drug Delivery Market, by Use, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Topical Drug Delivery Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Topical Drug Delivery Market Dynamics
- 3.1. Topical Drug Delivery Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. High prevalence of skin diseases
- 3.1.1.2. Rising prevalence of eye diseases
- 3.1.2. Market Challenges
- 3.1.2.1. Preference for alternative modes of drug delivery
- 3.1.3. Market Opportunities
- 3.1.3.1. Delivery of biologics through the transdermal route
Chapter 4. Global Topical Drug Delivery Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Topical Drug Delivery Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Topical Drug Delivery Market by Product, Performance - Potential Analysis
- 6.3. Global Topical Drug Delivery Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
- 6.4. Topical Drug Delivery Market, Sub Segment Analysis
- 6.4.1. Semi-Solid Formulations
- 6.4.2. Liquid Formulations
- 6.4.3. Solid Formulations
- 6.4.4. Transdermal Products
Chapter 7. Global Topical Drug Delivery Market, by Use
- 7.1. Market Snapshot
- 7.2. Global Topical Drug Delivery Market by Use, Performance - Potential Analysis
- 7.3. Global Topical Drug Delivery Market Estimates & Forecasts by Use, 2019-2028 (USD Billion)
- 7.4. Topical Drug Delivery Market, Sub Segment Analysis
- 7.4.1. Home Care Settings
- 7.4.2. Hospitals & Clinics
- 7.4.3. Burn Centers
- 7.4.4. Other Facilities
Chapter 8. Global Topical Drug Delivery Market, Regional Analysis
- 8.1. Topical Drug Delivery Market, Regional Market Snapshot
- 8.2. North America Topical Drug Delivery Market
- 8.2.1. U.S. Topical Drug Delivery Market
- 8.2.1.1. Product breakdown estimates & forecasts, 2019-2028
- 8.2.1.2. Use breakdown estimates & forecasts, 2019-2028
- 8.2.2. Canada Topical Drug Delivery Market
- 8.3. Europe Topical Drug Delivery Market Snapshot
- 8.3.1. U.K. Topical Drug Delivery Market
- 8.3.2. Germany Topical Drug Delivery Market
- 8.3.3. France Topical Drug Delivery Market
- 8.3.4. Spain Topical Drug Delivery Market
- 8.3.5. Italy Topical Drug Delivery Market
- 8.3.6. Rest of Europe Topical Drug Delivery Market
- 8.4. Asia-Pacific Topical Drug Delivery Market Snapshot
- 8.4.1. China Topical Drug Delivery Market
- 8.4.2. India Topical Drug Delivery Market
- 8.4.3. Japan Topical Drug Delivery Market
- 8.4.4. Australia Topical Drug Delivery Market
- 8.4.5. South Korea Topical Drug Delivery Market
- 8.4.6. Rest of Asia Pacific Topical Drug Delivery Market
- 8.5. Latin America Topical Drug Delivery Market Snapshot
- 8.5.1. Brazil Topical Drug Delivery Market
- 8.5.2. Mexico Topical Drug Delivery Market
- 8.6. Rest of The World Topical Drug Delivery Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. Cipla Ltd (India)
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Johnson & Johnson (US)
- 9.2.3. Nestle SA (Switzerland)
- 9.2.4. Novartis AG (Switzerland)
- 9.2.5. GlaxoSmithKline (UK)
- 9.2.6. Bausch Health Companies (Canada)
- 9.2.7. Merck & Co (US)
- 9.2.8. Bayer AG (Germany)
- 9.2.9. Hisamitsu Pharmaceutical (Japan)
- 9.2.10. Glenmark Pharmaceuticals (India)
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption